leisure time -WSS

leisure time

author：Wikipedia 2025-09-27 16:35:41 - browse：28

Telehealth menopause treatment options displayed on cellphones emerging from a crack in the ground. -- health tech coverage from STAT — Molly Ferguson for STAT

At the turn of the century, nearly 18 million women in the United States were battling hot flashes, night sweats, and other symptoms of menopause with hormones. But in 2002, the therapy went into a free-fall when a landmark trial suggested treating menopause with estrogen and progesterone increased the risk of breast cancer and cardiovascular disease. The study was shut down early — and a year later, prescriptions had plummeted to nearly half what they had been in 2001.

More than two decades later, menopause experts have come to think about the results of the trial very differently. Newer research points to more benefits than risks for many healthy women under 60 treating menopause symptoms with hormone therapy. But many women who are good fits still aren’t getting treatment. “The pendulum has been slowly — too slowly — swinging back,” said OB-GYN Mike Green, chief medical officer of menopause telehealth company Winona.

Winona is part of a new generation of virtual-first health care companies aiming to give that pendulum a push. In the last five years, more than a dozen telehealth companies have started up to serve women in and approaching menopause, including with hormone therapy.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： AstraZeneca chief proposes a novel edit to the drug pricing bill

WSS

Congress must reauthorize a committee to support older Americans

NIH nominee Bertagnolli will get October confirmation hearing

Readout Newsletter: The latest at Gilead, Catalent, and the NIH

NIH nominee Bertagnolli will get October confirmation hearing

NYU radiologists take on the challenge of expensive MRI machines

How generative AI is inspiring dreams of a health data revolution

focus

leisure time

entertainment

As demand for Covid shots wanes, Moderna seeks its next success

NYU radiologists take on the challenge of expensive MRI machines

Anesthesiologist group: stop taking Ozempic before surgery

Astellas still sees hope in its gene therapy after four deaths

In age of alternative facts, a scholarly course on calling out crap

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

Moonlake's readout produced a cash windfall. Risks remain

Hospitals look to new technology to keep health care workers safe

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Covid hospitalizations on the rise, Humana says

explore

Why medical students are struggling with mental health

Crinetics acromegaly drug succeeds in late

Covid hospitalizations on the rise, Humana says

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

House transparency, PBM reform bill gains bipartisan support

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

hotspot

leisure time

focus

leisure time